← Evidence map

Observational studyScientific reports2025

Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.

Crhistian-Mario Oblitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry. | OpenQuestion